ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

DOCS Dr. Martens Plc

90.20
-24.60 (-21.43%)
30 Nov 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Dr. Martens Plc LSE:DOCS London Ordinary Share GB00BL6NGV24 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -24.60 -21.43% 90.20 20,103,714 16:35:13
Bid Price Offer Price High Price Low Price Open Price
91.00 91.70 95.00 79.10 94.75
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Footwear-wholesale 1B 128.9M 0.1288 7.14 920.01M
Last Trade Time Trade Type Trade Size Trade Price Currency
18:28:47 O 25,487 88.725 GBX

Dr. Martens (DOCS) Latest News (10)

Dr. Martens (DOCS) Discussions and Chat

Dr. Martens Forums and Chat

Date Time Title Posts
30/11/202323:33Dr. Martens507
14/2/202116:55Dr Martens - just mucking about (please ignore)10

Add a New Thread

Dr. Martens (DOCS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2023-11-30 18:28:4788.7325,48722,613.34O
2023-11-30 18:28:4691.302,7272,489.67O
2023-11-30 18:28:4288.26161,139142,214.84O
2023-11-30 18:10:0089.461,6551,480.55O
2023-11-30 18:10:0090.5834,84731,565.11O

Dr. Martens (DOCS) Top Chat Posts

Top Posts
Posted at 30/11/2023 08:20 by Dr. Martens Daily Update
Dr. Martens Plc is listed in the Footwear-wholesale sector of the London Stock Exchange with ticker DOCS. The last closing price for Dr. Martens was 114.80p.
Dr. Martens currently has 1,000,557,598 shares in issue. The market capitalisation of Dr. Martens is £920,012,711.
Dr. Martens has a price to earnings ratio (PE ratio) of 7.14.
This morning DOCS shares opened at 94.75p
Posted at 30/11/2023 15:03 by red_star
Just jumped into docs with a little nibble. LFG!!!
Posted at 30/11/2023 12:25 by brucie5
This has now fallen beyond the 80% mark; which afaic is often the point at which a falling/surviving share begins to bottom out. Equally, beneath the £1 psychological threshold the journey down can be brutal as all residual weak holders get out, for fear of worse. It's pretty much like the end of a bungee-jump; but as long as the cord itself remains intact, you still have the prospect of getting back onto your feet.

I notice quite a lot of debt (294m). Has anyone flagged up concerns about that?

Against which, this:
-------------------------------------------------------------------------------------------------------------------------

Dr. Martens plc (the Company) has distributable reserves of GBP1,312.1m.

RETURNS TO SHAREHOLDERS

Our capital allocation philosophy guides our view of returns to shareholders and usage of excess cash. The first priority for investment is into the business and we will continue to invest in a targeted manner to support long-term growth and resilience of the Group. This is mainly represented by investment into marketing, logistics, people, systems and inventory. Beyond this, our priority is to return excess cash to shareholders, through a regular dividend and, when possible, further returns.

Dividends

The Board has approved and the Company has declared an interim dividend of 1.56p per share (H1 FY23: 1.56p). The interim dividend will be paid to shareholders on the register as at 5 January 2024 with payment on 2 February 2024.
Posted at 30/11/2023 11:03 by brucie5
Reviewed by roland Head on Stocko this morning; with this conclusion -

hxxps://app.stockopedia.com/content/small-cap-value-report-thu-30-nov-2023-pos-wyn-at-mul-docs-981676?order=createdAt&sort=desc&mode=threaded

Roland’s view

I think that a lot will depend on H2 trading and whether Dr Martens can finally get its US operations under control and performing effectively.

Although I think this is a decent brand with a reasonably positive future, I am not tempted to try catching this falling knife at the moment. I would prefer to wait for some signs of stability and a return to growth before considering an investment.

There might be an opportunity here -- I don’t know. But given the potential risks from rising leverage and the repeated disappointments this business has delivered since its IPO, I’m going to go AMBER/RED for now.
Posted at 15/11/2023 16:33 by velocytongo
100 sounds like the law of big numbers, CT. Also, people who say they'll buy at 100p then say, I'll wait until 90p and on it goes.

I've no idea whether it will hit 100p but the current valuation is 5x EV/EBITDA and 6.5 x EV/EBIT is just way too cheap for a brand like DMs. The DTC strategy makes perfect sense to control pricing and protect the brand. Jamming wholesale boosts revenues and profits (to help the float!) but damages the brand. Docs end up becoming destination stores in major retail areas. Just check out Covent Garden. It's interesting that Permira has not offloaded shares into the buyback.

I suspect that sales and profit growth will be slower going forward. So the share buybacks should boost EPS and buying them back at depressed levels makes perfect sense from a capital allocation point of view. I suspect that they will be spending £50m or 50% of free cash on buybacks as long as the business continues to perform.

The reservation I have is that debt is now quite expensive and will depress the impact of the buyback on EPS. I suspect they may stop buying back for this reason.

This is one of the few UK-listed companies that has a genuine global runway and lots of potential in the US. My friends' daughters in the US all love them and they appear to be a right of passage among middle-class kids in N London.

Apologies for the ramble but the final point is that this would be very attractive of another brand focussed company.
Posted at 14/11/2023 21:42 by seagreen
Tiger unless the IBK in charge of buybacks shorted the shares prior to their buybacks I do not get the share price movement but they may well yet be proven to have hit a home run with their low priced share buy backs...presumable because they are very confident they have enough spare cash?
Otherwise they would be committing financial suicide?
Posted at 19/10/2023 11:36 by mozy123
At least there is a company that buys back shares at a weak share price instead of multi year highs like most buy backs. Removing equity at this price is good business.
Posted at 11/10/2023 11:54 by rob_davis
Find it hard to reconcile spending £25m on a share buy back since July, with a decreasing share price during the same time. Doesn't figure
Posted at 20/9/2023 11:56 by seagreen
kash old chap there was a higher high in May/June 2023 the global brand is established the reason for the fall in sales due to the USA is well documented it is now being rectified it is a recovery story there is a share buy back program in play because the BOD's feel the share price has fallen too much and it makes sense. Interest rates are falling the art of spivy little margined short selling bets is coming to its end as the economy is turning, Maybe best to close your short and buy a few for the long term in an ISA.

But it is a free world, but your dishonest posts may become increasingly obvious and purile.
Posted at 14/4/2023 12:32 by kalai1
Dr. Martens plc issued a year end trading update and also an update on problems at its LA Distribution Centre this morning. For the full year, revenue growth was 10%, Q4 revenue was up 6%. Management now expect FY23 EBITDA to be around £245m due to higher costs at the Group’s LA DC and lower wholesale revenue. Good progress has been made on resolving the operational issues at the LA DC, which began impacting the America wholesale channel from December. Shipment volumes are now back to normal levels. In FY23, total incremental costs associated with the LA DC were c.£15m, higher than the £8-11m expected initially. The outlook remains solid, management are maintaining FY24 revenue growth guidance of mid to high single digits on a constant currency basis. Valuation is attractive following a near 80% share price correction with forward PE ratio at 10x, the business remains profitable. Share price lacks positive momentum for now, but today’s release has triggered a 10% spike so far today. There is a lot to like here. BUY...

...from WealthOracle
Posted at 28/11/2022 14:32 by essentialinvestor
As the DOCS share price is given to large % moves in either direction, there are likely
to be ample trading opportunities for those astute/lucky enough to catch some
of those.
Dr. Martens share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com